Status:
COMPLETED
Efficacy of Platelet Rich Plasma Injection in Diabetic Neuropathy
Lead Sponsor:
Assiut University
Conditions:
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
To evaluate the clinical efficacy and safety of peri-neural platelet rich plasma (PRP) injection in the treatment of diabetic peripheral neuropathy compared to traditional medical treatment.
Detailed Description
Background: Neuropathy is a common complication of diabetes mellitus (DM) with a wide clinical spectrum that encompasses generalized to focal and multifocal forms not only leads to an impaired quality...
Eligibility Criteria
Inclusion
- Diabetic peripheral neuropathy of at least 5 years duration of symptoms
Exclusion
- hereditary neuropathies , entrapment neuropathies , connective tissue diseases , vertebral diseases , thyroid disorders and end organ failure
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03250403
Start Date
April 1 2017
End Date
October 1 2017
Last Update
July 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University
Asyut, Egypt, 7111